Nanjing Pharmaceutical Group Company Limited Class ASSE: 600713

"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026

Sep 16, 2026 · Issued by Nanjing Pharmaceutical Group Company Limited Class A via Shanghai Stock Exchange

Filed with SSE · Sep 16, 2026

Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Nanjing Pharmaceutical Group Company Limited Class A

"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Implementation of Dividend Distribution for the First Half of 2026Sep 10
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Redemption upon Maturity of Cash Management Products Purchased with Certain Temporarily Idle Raised Funds and Continued Cash Management by the Company and Its SubsidiarySep 9
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Convening the 2026 Semi-annual Performance BriefingSep 8
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Indicative Announcement on Suspension of Conversion of "NANJING PHARMACEUTICAL Convertible Bonds" During the Implementation of Interim Dividend Distribution for 2026Sep 4

All Nanjing Pharmaceutical Group Company Limited Class A news releases